Perspective Therapeutics, Inc. (CATX)
3.18
-0.12
(-3.64%)
USD |
NYAM |
Aug 24, 16:00
3.18
0.00 (0.00%)
After-Hours: 19:58
Perspective Therapeutics Debt to Equity Ratio : 0.0122 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0122 |
| March 31, 2026 | 0.0122 |
| December 31, 2025 | 0.0157 |
| September 30, 2025 | 0.0137 |
| June 30, 2025 | 0.0134 |
| March 31, 2025 | 0.0134 |
| December 31, 2024 | 0.014 |
| September 30, 2024 | 0.013 |
| June 30, 2024 | 0.0114 |
| March 31, 2024 | 0.0125 |
| September 30, 2023 | 0.0335 |
| June 30, 2023 | 0.0237 |
| March 31, 2023 | 0.0179 |
| June 30, 2022 | 0.0086 |
| March 31, 2022 | 0.0093 |
| December 31, 2021 | 0.0101 |
| September 30, 2021 | 0.0109 |
| June 30, 2021 | 0.0115 |
| March 31, 2021 | 0.0123 |
| December 31, 2020 | 0.0702 |
| September 30, 2020 | 0.1876 |
| June 30, 2020 | 0.1756 |
| March 31, 2020 | 0.1825 |
| December 31, 2019 | 0.1821 |
| September 30, 2019 | 0.1687 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| MiMedx Group, Inc. | 0.0797 |
| ABVC BioPharma, Inc. | 0.2807 |
| Enovis Corp. | 0.9269 |
| Edwards Lifesciences Corp. | 0.0663 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 392.02M |
| Total Liabilities (Quarterly) | 68.16M |
| Shareholders Equity (Quarterly) | 323.86M |
| Current Ratio | 6.609 |
| Net Debt Paydown Yield | -0.01% |